GL1X · GenesisL1 explorer

MolNFT v1 · #96324 · protein

Crystal structure of human dihydroorotate dehydrogenase (dhodh) with DH03A016

4JGD · Dihydroorotate dehydrogenase (quinone), mitochondrial: “Crystal structure of human dihydroorotate dehydrogenase (dhodh) with DH03A016”. X-ray diffraction, 5 ligands (FMN, ORO, DET), 5 pockets (best druggability 0.83). MolNFT v1…

PDB
4JGD
Type
protein
Length
364 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, DET, 4JG, SO4
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (quinone), mitochondrial (EC 1.3.5.2)protein36446% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • DET · Undecylamine-N,N-dimethyl-N-oxide · ligand · chains A
  • 4JG · 1-[4-methyl-2-(naphthalen-2-ylamino)-1,3-thiazol-5-yl]ethanone · ligand · chains A
  • SO4 · Sulfate ion · ion · 9 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14310.830.9162FMN, ORO, 4JG
2940.440.8019DET
3510.410.8217SO4
4890.400.7820empty
5790.360.7619empty

Compared structures

  • 4JGD · Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A016 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.